25 January 2010
Infosys at the 4th Annual Pharmaceutical PLM Conference on March 3-4, 2010
Date: March 3-4, 2010
Time: 09:00 – 17:00 GMT
Venue: BSG Conference Centre, London, U.K.
Pharmaceutical and biopharmaceutical companies are under pressure to improve the pipeline of new products and accelerate time-to-market. They also face challenges in increasing the margins of existing products, while adhering to quality principles and regulatory requirements. It is imperative that companies address these challenges to stay competitive, increase revenue, enhance profit, and reduce the risk of non-compliance.
Visiongain's 4th Annual Pharmaceutical PLM Conference features keynote addresses, presentations, case studies, and interactive discussions from development to commercialization, quality control, supplier issues, regulation and inspection. The conference provides a platform for knowledge sharing and networking, with more than 20 luminaries from the pharmaceutical industry in attendance. Infosys is an Associate Sponsor of the conference. Their expert shares his perspective on an integrated PLM solution for the pharmaceutical industry.
Title: Towards an Integrated PLM Solution for the Pharmaceutical Industry – A Perspective
Date: March 3, 2010
Time: 09:40 – 10:20 GMT
Speaker: Amit Sharma, Head, PLM Europe, Product Lifecycle Engineering Services, Infosys Technologies.
Amit shares his perspective on how Product Lifecycle Management (PLM) should mature in an organization for comprehensive benefits from key PLM initiatives. He will focus on:
The PLM maturity model and challenges in the pharmaceutical industry
Solution ideation, as-is landscape and business goals
Case study and Infosys’ credentials
Learn more about the 4th Annual Pharmaceutical PLM Conference.
Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.
Tell us what you think of the CIMdata Newsletter. Send your feedback.
CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.